UPDATE: Horizon Therapeutics (HZNP) PT Raised to $90 at Piper Sandler Due to Tepezza and Krystexxa Results
Tweet Send to a Friend
(Updated - July 22, 2020 9:48 AM EDT)
Piper Sandler analyst David Amsellem raised the price target on Horizon ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem raised the price target on Horizon ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
